Development of molecular biomarker for colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Primary outcome(s): predictability of prognosis. predictability of chemo sensitivity.
应用场景：
创建时间：
2009-06-15
相关数据集
Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma
The prognosis of colorectal carcinoma (CRC) is unstable in the stage II-III patients. Patients with early stage II CRC have a relative poor prognosis while other stage III CRC patients have a better p
Figshare2017-08-11 更新180
Additional file 2 of Developing a multiomics data-based mathematical model to predict colorectal cancer recurrence and metastasis
Supplementary Material 2: Additional file 2– Supplementary Table S1: The detailed results of feature selection (the p values) are listed in Supplementary Table S1
NIAID Data Ecosystem80
DataSheet_1_A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma.pdf
ObjectivesThe study aims to analyze the expression of N6-methyladenosine (m6A)-modified genes in rectum adenocarcinoma (READ) and identify reliable prognostic biomarkers to predict the prognosis of RE
NIAID Data Ecosystem60
Additional file 9 of The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer
Additional file 9: Supplementary Table 6. The association between the depth of PNI and the site of metastasis in stage II CRC patients.
NIAID Data Ecosystem100
Ribosomal Protein S27-Like in Colorectal Cancer: A Candidate for Predicting Prognoses
Background The development and progression of colorectal cancer (CRC) involve a complex process of multiple genetic changes. Tumor suppressor p53 is capable of determining the fate of CRC cells. Howev
NIAID Data Ecosystem80
